ENDRA Life Sciences (NDRA) Cash from Investing Activities Growth (1y) (2020 - 2026)
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Cash from Investing Activities Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 48.43% |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 99.13% |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 74.84% |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | -8.71% |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | 99.44% |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | -800.00% |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | -225.15% |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2,704.17% |
| Mar 31, 2025 | 27.38% |
| Mar 31, 2024 | 11.87% |
| Dec 31, 2023 | 105.91% |
| Mar 31, 2023 | 69.78% |
| Mar 31, 2022 | -98.56% |
| Mar 31, 2021 | -101.34% |
| Dec 31, 2020 | -69.07% |
| Mar 31, 2020 | -326.61% |